Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer.

Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer.


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: فرهاد جدیدی نیارق , وحید کارپیشه , مهدی یوسفی , بهمن یوسفی , افشین نیک خو

کلمات کلیدی: Colon cancer; E-type; cyclooxygenase-2; prostaglandin E2; prostanoid receptor

نشریه: 28414 , 1 , 144 , 2019

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله فرهاد جدیدی نیارق
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات ایمونولوژی
کد مقاله 66966
عنوان فارسی مقاله Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer.
عنوان لاتین مقاله Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer.
ناشر 9
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Review Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Although colon cancer is one of the most important triggers of cancer related mortality, a few therapeutic options exist for this disease, including combination chemotherapy, anti-EGFR and anti-angiogenic agents. However, none of these therapeutics are fully effective for complete remission, and this issue needs further investigations, particularly in the patients with advanced disease. It has been shown that colon carcinogenesis process is associated with upregulation of prostaglandin (PG) levels. Moreover, conversion of pre-malignant cells to malignant was also related with increased generation of PGs in susceptible subjects. Among the prostanoids, PGE2 is the most important produced member which generated in high levels by colon tumor cells. Generation of PGE2 by action of cyclooxygenase (COX)-2 can promote growth and development, resistance to apoptosis, proliferation, invasion and metastasis, angiogenesis and drug resistance in colon cancer. Increased levels of PGE2 and COX-2 in colon cancer is reported by various investigators which was associated with disease progression. It is suggested that there is a positive feedback loop between COX-2 and PGE2, in which function of COX-2 induces generation of PGE2, and upregulation of PGE2 increases the expression of COX-2 in colon cancer. Although an existence of this feedback loop is well-documented, its precise mechanism, signaling pathways, and the particular E-type prostanoid (EP) receptor mediating this feedback are elusive. Therefore, it seems that targeting COX-2/PGE2/EP receptors may be supposed as a potent therapeutic strategy for treatment of colon cancer. In this review, we try to clarify the role of PGE2 in cancer progression and its targeting for treatment of colon cancer.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
فرهاد جدیدی نیارقنهم
وحید کارپیشهاول
مهدی یوسفیهشتم
بهمن یوسفینهم
افشین نیک خودوم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer.pdf1398/07/081221895دانلود